VistaGen Therapeutics, Inc. (VTGN) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 65 transactions totaling $18.4M, demonstrating a bullish sentiment with $18.1M in net insider flow. The most recent transaction on Dec 31, 2025 involved a transaction of 4,386 shares valued at $2.5K.
No significant insider buying has been recorded for VTGN in the recent period.
No significant insider selling has been recorded for VTGN in the recent period.
Based on recent SEC filings, insider sentiment for VTGN is bullish with an Insider Alignment Score of 99/100 and a net flow of $18.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at VistaGen Therapeutics, Inc. (VTGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading VTGN stock, having executed 65 transactions in the past 90 days. The most active insider is Capital Lp Commodore (Executive), who has made 1 transactions totaling $18.0M.
Get notified when executives and directors at VTGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | S. Prince Joshua | Chief Operating Officer | Award | 4,386 | $0.56 | $2.5K | C-Suite |
| Jun 30, 2025 | Singh Shawn | Executive | Award | 7,541 | $1.70 | $12.8K | |
| Jun 30, 2025 | Lynn Anderson Cynthia | Executive | Award | 6,617 | $1.70 | $11.2K | |
| Jun 30, 2025 | G. Adler Reid | Executive | Award | 7,541 | $1.70 | $12.8K | |
| Jun 30, 2025 | S. Prince Joshua | Executive | Award | 4,882 | $1.70 | $8.3K | |
| Jun 28, 2024 | Singh Shawn | Executive | Award | 4,854 | $2.96 | $14.4K | |
| Jun 28, 2024 | G. Adler Reid | Executive | Award | 4,854 | $2.96 | $14.4K | |
| Jun 28, 2024 | Lynn Anderson Cynthia | Executive | Award | 3,592 | $2.96 | $10.6K | |
| Jun 28, 2024 | S. Prince Joshua | Executive | Award | 2,671 | $2.96 | $7.9K | |
| Dec 29, 2023 | Singh Shawn | Executive | Award | 167 | $1.72 | $287 | |
| Dec 29, 2023 | G. Adler Reid | Executive | Award | 167 | $1.72 | $287 | |
| Aug 7, 2023 | Lp Commodore Capital | Executive | Purchase | 775,756 | $23.15 | $18.0M | Large |
| Jun 30, 2023 | Duane Dotson Jerrold | Executive | Award | 167 | $1.59 | $266 | |
| Jun 30, 2023 | G. Adler Reid | Executive | Award | 167 | $1.59 | $266 | |
| Jun 30, 2023 | Singh Shawn | Executive | Award | 167 | $1.59 | $266 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $18.2M | 96.9% |
Exercise(M) | 14 | $262.0K | 1.4% |
Award(A) | 35 | $175.5K | 0.9% |
Sale(S) | 2 | $147.3K | 0.8% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at VistaGen Therapeutics, Inc. are accumulating shares at an accelerated pace. With 12 insiders making 65 transactions totaling $18.2M in purchases versus $147.3K in sales, the net buying activity of $18.1M signals strong executive confidence. Capital Lp Commodore (Executive) leads the buying activity with $18.0M in transactions across all time.